Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Stivarga

Bayer symbol

Bayer CEO Dekkers points to ‘outstanding’ pharma growth

On target to meet company’s annual expectations of €7.5bn

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

Pharma supports first World Thrombosis Day

Aims to raise awareness of the blood clot condition

- PMLiVE

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

Bayer symbol

Bayer to spin out material science division

German firm will focus solely on life sciences

- PMLiVE

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla

- PMLiVE

Pharma Perspectives with the HCC: Malik Akhtar on the pitching process

Bayer's category lead for agency services gives a pharma view

- PMLiVE

Pharma Perspectives with the HCC: Ben Davies on the pitching process

Havas Health's European CEO gives an agency view

Bayer symbol

Bayer wins GIST approval for Stivarga in EU

Cancer drug can be used after Pfizer’s Sutent and Novartis’ Glivec

- PMLiVE

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

- PMLiVE

Bayer names head of US litigation

Malini Moorthy joins from Pfizer

- PMLiVE

Bayer files eye drug Eylea for new use in EU

Aims to add branch retinal vein occlusion indication

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links